NEK2 and breast cancer: MicroRNA (miR)-128-3p inhibits the stem-like cell characteristics of breast cancer stem cells (BCSCs) by inhibiting the Wnt signaling pathway via downregulating NEK2, creating a new target for breast cancer treatment [21].